Cargando…

Could I-FABP Be an Early Marker of Celiac Disease in Children with Type 1 Diabetes? Retrospective Study from the Tertiary Reference Centre

Patients with type 1 diabetes (T1D) are at higher risk of celiac disease (CD). Recently, intestinal fatty acid binding protein (I-FABP) has been shown to be a serological biomarker of impaired intestinal barrier in CD. Thus, the aim of this study was to verify whether I-FABP could be an early marker...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochocińska, Agnieszka, Wysocka-Mincewicz, Marta, Groszek, Artur, Rybak, Anna, Konopka, Ewa, Bierła, Joanna Beata, Trojanowska, Ilona, Szalecki, Mieczysław, Cukrowska, Bożena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840733/
https://www.ncbi.nlm.nih.gov/pubmed/35276772
http://dx.doi.org/10.3390/nu14030414
_version_ 1784650692510613504
author Ochocińska, Agnieszka
Wysocka-Mincewicz, Marta
Groszek, Artur
Rybak, Anna
Konopka, Ewa
Bierła, Joanna Beata
Trojanowska, Ilona
Szalecki, Mieczysław
Cukrowska, Bożena
author_facet Ochocińska, Agnieszka
Wysocka-Mincewicz, Marta
Groszek, Artur
Rybak, Anna
Konopka, Ewa
Bierła, Joanna Beata
Trojanowska, Ilona
Szalecki, Mieczysław
Cukrowska, Bożena
author_sort Ochocińska, Agnieszka
collection PubMed
description Patients with type 1 diabetes (T1D) are at higher risk of celiac disease (CD). Recently, intestinal fatty acid binding protein (I-FABP) has been shown to be a serological biomarker of impaired intestinal barrier in CD. Thus, the aim of this study was to verify whether I-FABP could be an early marker of CD in pediatric T1D patients. I-FABP was measured in sera of patients with T1D (n = 156), active CD (n = 38), T1D with active CD (T1D-CD, n= 51), and age-matched healthy children (n = 55). Additionally, I-FABP was determined in T1D patients with negative CD serology at least one year before CD diagnosis (T1D-CD-1, n = 22), in CD patients on a gluten-free diet (CD-GFD, n = 36), and T1D-CD patients on GFD (T1D-CD-GFD, n = 39). Sera were tested using immunoenzymatic assay. Significantly increased levels of I-FABP were found in the T1D, active CD, and T1D-CD groups (1153 ± 665, 1104 ± 916, and 1208 ± 878, respectively) in comparison to healthy with controls (485 ± 416, p < 0.05). GFD induced a significant decrease in I-FABP levels in CD and T1D-CD groups (510 ± 492 and 548 ± 439, respectively). Interestingly, in T1D-CD-1 and T1D, I-FABP levels were comparable (833 ± 369 vs. 1153 ± 665), and significantly increased in relation to healthy controls and T1D-CD values on GFD. The results indicate that the epithelial barrier is disrupted in T1D patients independently of CD development; therefore, I-FABP cannot serve as an early marker of CD in T1D patients. Although GFD can improve epithelial recovery, the question remains as to whether GFD could exert beneficial effects on the intestinal barrier in early stages of T1D.
format Online
Article
Text
id pubmed-8840733
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88407332022-02-13 Could I-FABP Be an Early Marker of Celiac Disease in Children with Type 1 Diabetes? Retrospective Study from the Tertiary Reference Centre Ochocińska, Agnieszka Wysocka-Mincewicz, Marta Groszek, Artur Rybak, Anna Konopka, Ewa Bierła, Joanna Beata Trojanowska, Ilona Szalecki, Mieczysław Cukrowska, Bożena Nutrients Article Patients with type 1 diabetes (T1D) are at higher risk of celiac disease (CD). Recently, intestinal fatty acid binding protein (I-FABP) has been shown to be a serological biomarker of impaired intestinal barrier in CD. Thus, the aim of this study was to verify whether I-FABP could be an early marker of CD in pediatric T1D patients. I-FABP was measured in sera of patients with T1D (n = 156), active CD (n = 38), T1D with active CD (T1D-CD, n= 51), and age-matched healthy children (n = 55). Additionally, I-FABP was determined in T1D patients with negative CD serology at least one year before CD diagnosis (T1D-CD-1, n = 22), in CD patients on a gluten-free diet (CD-GFD, n = 36), and T1D-CD patients on GFD (T1D-CD-GFD, n = 39). Sera were tested using immunoenzymatic assay. Significantly increased levels of I-FABP were found in the T1D, active CD, and T1D-CD groups (1153 ± 665, 1104 ± 916, and 1208 ± 878, respectively) in comparison to healthy with controls (485 ± 416, p < 0.05). GFD induced a significant decrease in I-FABP levels in CD and T1D-CD groups (510 ± 492 and 548 ± 439, respectively). Interestingly, in T1D-CD-1 and T1D, I-FABP levels were comparable (833 ± 369 vs. 1153 ± 665), and significantly increased in relation to healthy controls and T1D-CD values on GFD. The results indicate that the epithelial barrier is disrupted in T1D patients independently of CD development; therefore, I-FABP cannot serve as an early marker of CD in T1D patients. Although GFD can improve epithelial recovery, the question remains as to whether GFD could exert beneficial effects on the intestinal barrier in early stages of T1D. MDPI 2022-01-18 /pmc/articles/PMC8840733/ /pubmed/35276772 http://dx.doi.org/10.3390/nu14030414 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ochocińska, Agnieszka
Wysocka-Mincewicz, Marta
Groszek, Artur
Rybak, Anna
Konopka, Ewa
Bierła, Joanna Beata
Trojanowska, Ilona
Szalecki, Mieczysław
Cukrowska, Bożena
Could I-FABP Be an Early Marker of Celiac Disease in Children with Type 1 Diabetes? Retrospective Study from the Tertiary Reference Centre
title Could I-FABP Be an Early Marker of Celiac Disease in Children with Type 1 Diabetes? Retrospective Study from the Tertiary Reference Centre
title_full Could I-FABP Be an Early Marker of Celiac Disease in Children with Type 1 Diabetes? Retrospective Study from the Tertiary Reference Centre
title_fullStr Could I-FABP Be an Early Marker of Celiac Disease in Children with Type 1 Diabetes? Retrospective Study from the Tertiary Reference Centre
title_full_unstemmed Could I-FABP Be an Early Marker of Celiac Disease in Children with Type 1 Diabetes? Retrospective Study from the Tertiary Reference Centre
title_short Could I-FABP Be an Early Marker of Celiac Disease in Children with Type 1 Diabetes? Retrospective Study from the Tertiary Reference Centre
title_sort could i-fabp be an early marker of celiac disease in children with type 1 diabetes? retrospective study from the tertiary reference centre
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840733/
https://www.ncbi.nlm.nih.gov/pubmed/35276772
http://dx.doi.org/10.3390/nu14030414
work_keys_str_mv AT ochocinskaagnieszka couldifabpbeanearlymarkerofceliacdiseaseinchildrenwithtype1diabetesretrospectivestudyfromthetertiaryreferencecentre
AT wysockamincewiczmarta couldifabpbeanearlymarkerofceliacdiseaseinchildrenwithtype1diabetesretrospectivestudyfromthetertiaryreferencecentre
AT groszekartur couldifabpbeanearlymarkerofceliacdiseaseinchildrenwithtype1diabetesretrospectivestudyfromthetertiaryreferencecentre
AT rybakanna couldifabpbeanearlymarkerofceliacdiseaseinchildrenwithtype1diabetesretrospectivestudyfromthetertiaryreferencecentre
AT konopkaewa couldifabpbeanearlymarkerofceliacdiseaseinchildrenwithtype1diabetesretrospectivestudyfromthetertiaryreferencecentre
AT bierłajoannabeata couldifabpbeanearlymarkerofceliacdiseaseinchildrenwithtype1diabetesretrospectivestudyfromthetertiaryreferencecentre
AT trojanowskailona couldifabpbeanearlymarkerofceliacdiseaseinchildrenwithtype1diabetesretrospectivestudyfromthetertiaryreferencecentre
AT szaleckimieczysław couldifabpbeanearlymarkerofceliacdiseaseinchildrenwithtype1diabetesretrospectivestudyfromthetertiaryreferencecentre
AT cukrowskabozena couldifabpbeanearlymarkerofceliacdiseaseinchildrenwithtype1diabetesretrospectivestudyfromthetertiaryreferencecentre